A study of adverse drug reactions in patients receiving treatment for multidrug-resistant tuberculosis in a tertiary care center

Background: The emergence of multidrug-resistant tuberculosis (MDR-TB) (defined as resistance to at least isoniazid and rifampin) poses a threat to global TB control. Second line drugs are frequently associated with very high rates of unacceptable adverse drug reactions (ADRs), needing frequent inte...

Descripció completa

Dades bibliogràfiques

Autors principals:	Swapnil Gupta, Vinod Kumar Jangid, Suman Khangarot, Anil Saxena, Kishore Kameliya
Format:	Artigo
Idioma:	Inglês
Publicat:	Eldaghayes Publisher 2022-08-01
Col·lecció:	National Journal of Physiology, Pharmacy and Pharmacology
Matèries:	multidrug-resistant tuberculosis; adverse drug reaction; second line anti tb drugs
Accés en línia:	http://www.ejmanager.com/fulltextpdf.php?mno=39869
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!